Nitin D. Gaikwad
Nitin D. Gaikwad publishes mostly in Organic Chemistry, Molecular Biology and Biochemistry, on topics such as Synthesis and biological activity, Multicomponent Synthesis of Heterocycles and Phenothiazines and Benzothiazines Synthesis and Activities.
- World rank
- #4,053,755 of 7,710,434 ranked researchers
- Rank in India
- #97,605 of 280,097
- Works
- 31
- Citations
- 325
- Citations per work
- 10.5
What does Nitin D. Gaikwad research?
Nitin D. Gaikwad's work is mostly in Chemistry (75%), Biochemistry, Genetics and Molecular Biology (14%), Medicine (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2375.5%
- Chemistry2375.5%
- Life Sciences515.5%
- Everything else26.8%
- Health Sciences12.2%
- Medicine12.2%
- 1Organic Chemistry73% of their works
- 2Molecular Biology11% of their works
- 3Biochemistry3% of their works
- 4Spectroscopy2% of their works
- 5Pharmacology2% of their works
- 6Pharmacology1% of their works
Research topics
- Synthesis and biological activity
- Multicomponent Synthesis of Heterocycles
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
- Catalytic C–H Functionalization Methods
- Synthesis and Reactivity of Heterocycles
Which keywords describe Nitin D. Gaikwad's research?
The keywords of their largest research topics: Drug Discovery, Heterocyclic Compounds, Anticancer Agents, Medicinal Chemistry, Synthesis, Tubulin Inhibitors, Vascular Targeting Agents and Biological Evaluation.
- Indolizines
- Bioactivity
- Derivatives
- Click Chemistry
- Scaffold
- Biological Activities
- Molecular Docking
- Antimicrobial
- Multicomponent Reactions
- Biological Evaluation
- Tubulin Inhibitors
- Medicinal Chemistry
- Heterocyclic Compounds
- Drug Discovery
- Anticancer Agents
- Synthesis
- Vascular Targeting Agents
- Green Chemistry
- Anticancer
- Heterocycles
- Antimicrobial Activity
- Phenothiazines
- Triazines
- Copper-Catalyzed Cycloaddition
- Quinoxaline
- C–H Activation
- Transition Metal Catalysis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 27 words, with their numbers
- Drug Discovery213 topics
- Heterocyclic Compounds213 topics
- Anticancer Agents182 topics
- Medicinal Chemistry182 topics
- Synthesis174 topics
- Tubulin Inhibitors141 topic
- Vascular Targeting Agents141 topic
- Biological Evaluation123 topics
- Green Chemistry121 topic
- Multicomponent Reactions121 topic
- Anticancer102 topics
- Antimicrobial102 topics
- Heterocycles82 topics
- Molecular Docking82 topics
- Antimicrobial Activity72 topics
- Biological Activities51 topic
- Phenothiazines51 topic
- Scaffold51 topic
- Triazines51 topic
- Click Chemistry41 topic
- Copper-Catalyzed Cycloaddition41 topic
- Derivatives41 topic
- Quinoxaline41 topic
- Bioactivity31 topic
- C–H Activation31 topic
- Indolizines31 topic
- Transition Metal Catalysis31 topic
Where does Nitin D. Gaikwad work?
Nitin D. Gaikwad's main affiliation in the publication record is Savitribai Phule Pune University, India.
How many publications and citations does Nitin D. Gaikwad have?
OpenAlex counts 31 works and 325 citations for Nitin D. Gaikwad, an h-index of 9, ranking #4,053,755 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nitin D. Gaikwad. Posts are plain text and can be reported.